UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

☐		Preliminary Proxy Statement
☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐		Definitive Proxy Statement
☒		Definitive Additional Materials
☐		Soliciting Material Pursuant to §240.14a-12

DESTINATION MATERNITY

CORPORATION

(Name of Registrant as Specified In Its Charter)

NOT APPLICABLE

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒		No fee required.
☐		Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
		(1)		Title of each class of securities to which transaction applies:
		(2)		Aggregate number of securities to which transaction applies:
		(3)		Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
		(4)		Proposed maximum aggregate value of transaction:
		(5)		Total fee paid:
☐		Fee paid previously with preliminary materials.
☐		Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
		(1)		Amount Previously Paid:
		(2)		Form, Schedule or Registration Statement No.:
		(3)		Filing Party:
		(4)		Date Filed:         Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 

---

232 Strawbridge Drive, Moorestown, NJ 08057 • 856.291.9700 • destinationmaternitycorp.com

May 18, 2018

Via e-mail and U.S. Mail

Nathan G. Miller

c/o NGM Asset Management, LLC

27 Pine Street, Suite 700

New Canaan, CT 06840

Dear Mr. Miller,

I write in response to your May 18, 2018 letter to the board of directors (the “Board”) of Destination Maternity Corporation (the “Company”).

As a preliminary matter, we vigorously dispute your assertion that the Board has taken any improper actions to disenfranchise the Company’s stockholders, with respect to the Company’s 2018 annual meeting or otherwise. To the contrary, the Board has acted consistent with its fiduciary duties to the Company’s stockholders at all times.

We specifically disagree with your inaccurate characterization of the April 2, 2018 Support Agreement (the “Orchestra Agreement”) between the Company and Orchestra-Prémaman S.A. and its affiliate (“Orchestra”) for two reasons. First, voting agreements such as the Orchestra Agreement are far from unprecedented. Rather, companies and stockholders frequently enter into such agreements to achieve mutually beneficial goals. Second, your depiction of the Orchestra Agreement as an illegal mechanism to disenfranchise voters and reduce the Board’s accountability to stockholders is wrong and baseless. The Orchestra Agreement is proper and valid.

Less than two months ago, you stated publicly that you and your Board candidates “…would support expanding the Board and adding representatives of [Orchestra] to the Board, if Orchestra desires such representation, so that the Board will include additional stockholder representation.” Yet now you are attacking the Board’s action in doing just that, and in the process you are trying to deprive the Company’s largest stockholder of its right to vote its shares as it sees fit. We are perplexed by the conflict inherent in your shifting positions, and are unable to reconcile this conflict.

These desperate efforts and groundless accusations appear intended for no purpose other than to distract our stockholders from the clear choice between the Company’s highly qualified director nominees and your inexperienced and under-qualified candidates. We strongly urge you to allow a fair and transparent election to be held without these improper, misleading efforts to confuse and distract our stockholders.

The Board has always acted in the best interests of all Company stockholders, and looks forward to continuing to do so into the future. The Company and the Board reserve all of their rights and remedies.